Mounjaro®
Starting from £179.99/mo
Start journey Learn moreExcess gas, bloating and burping are among the most commonly reported side effects of Mounjaro (tirzepatide). They arise because tirzepatide slows the rate at which food leaves the stomach, giving gut bacteria more time to ferment undigested carbohydrates — a predictable consequence of the medicine's mechanism, documented in the SURMOUNT-1 trial and consistent with NHS guidance on tirzepatide side effects. Most people notice gas most during the first few weeks or after a dose increase, and the symptom usually settles. Understanding why it happens makes it considerably easier to manage, and, reassuringly, it rarely signals anything clinically worrying.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide's gastrointestinal side-effect profile was studied across thousands of adults in the SURMOUNT clinical programme, SURMOUNT-1 alone enrolled 2,539 participants over 72 weeks. Gas-related complaints, including flatulence, belching and abdominal distension, appeared consistently in the treatment arm, particularly in the early months of therapy. The SURMOUNT-1 paper published in the New England Journal of Medicine grouped these under gastrointestinal adverse events and noted they were mostly mild to moderate in severity.
NHS guidance describes burping, indigestion and wind as common effects of tirzepatide, framing them as expected rather than alarming. That framing matters: knowing the symptom is well-characterised and time-limited is genuinely different from wondering whether something has gone wrong. If you are also experiencing noticeable bloating, the mechanism overlaps significantly with what causes excess gas, and both tend to respond to the same practical changes.
One caveat worth holding onto: severe, persistent stomach pain (particularly if it radiates through to the back) is different from ordinary gassiness. That pattern warrants same-day medical attention, as pancreatitis is a known infrequent risk with GLP-1 class medicines. Ordinary gas does not feel like that.
Tirzepatide acts on both GIP and GLP-1 receptors, which together reduce appetite and slow gastric emptying. That second effect is central to how Mounjaro works: food sits in the stomach longer, and digestion proceeds more gradually down the small intestine. The upside is sustained fullness. The side effect is that partially digested carbohydrates (starches, sugars, fibre) reach the large intestine less processed, where resident bacteria ferment them and produce hydrogen and carbon dioxide gas.
This is essentially the same mechanism that makes high-fibre foods gassy for many people, just triggered and amplified by the medicine rather than a single meal. The stomach also produces more swallowed air when it is distended and working more slowly, which contributes to burping specifically. If you want a closer look at why Mounjaro causes gassiness and the specific foods most likely to make it worse, we cover the detail there.
Dose increases temporarily reset the threshold. The starter dose of 2.5mg exists largely to let the digestive system adapt gradually; each step up revisits that adjustment period in a milder form. Most people find the second or third dose at any new level noticeably more comfortable than the first.
No single fix works for everyone, but several approaches have a reasonable basis and are consistent with what our clinical team hears from patients managing this well.
Eating pace matters more than people expect. Slower eating reduces swallowed air and gives digestive enzymes more time per bite, which means fewer partially digested fragments reaching the colon. Smaller portions, eaten across more sittings, can achieve the same effect, Mounjaro already suppresses appetite enough that this is rarely a hardship.
Temporarily pulling back on the highest-fermentation foods during a dose-increase window is worth trying: carbonated drinks, cruciferous vegetables in large quantities, beans and lentils, and sugar alcohols (common in low-calorie snacks and chewing gum) are the main culprits. You do not need to eliminate them permanently; just ease off while your gut adjusts.
Staying well hydrated helps gut motility along, which prevents fermentable material sitting in the colon any longer than necessary. Some people find a short walk after eating noticeably helpful for the same reason.
If gassiness is significantly affecting daily life at a particular dose, that is exactly the kind of thing worth raising before moving to the next rung. Prescribers sometimes recommend staying at a dose for an extra week or two rather than increasing on the standard schedule. This flexibility is one reason clinical oversight across every repeat matters, you can read about what that ongoing oversight is priced to include if cost context is useful.
The vast majority of gas on Mounjaro is benign and manageable. There are, however, a few patterns that shift it from nuisance into something to flag promptly. Severe nausea alongside significant gas, particularly with vomiting that prevents adequate hydration, can lead to dehydration quickly, that warrants contact with a clinician or NHS 111. Persistent upper abdominal pain or pain that spreads to the shoulder or back alongside GI symptoms should be assessed the same day; these patterns can indicate gallbladder or pancreatic involvement, both of which carry a small but real association with tirzepatide.
For anything else (ordinary wind, burping after meals, mild bloating that comes and goes) time and the small adjustments above are usually sufficient. If you are finding Mounjaro particularly gassy and want reassurance about what sits within the normal range, our aftercare team is available seven days a week alongside our FAQs, which cover a range of common questions.
It is also worth knowing that some cold sensitivity and other less expected changes occasionally appear alongside GI effects; feeling unusually cold on Mounjaro is another query our prescribers see regularly, and the explanation is similarly grounded in the medicine's mechanism.
If you are considering starting treatment and want to talk through how these side effects are managed from day one, our prescribers review every consultation personally. Some people also ask why they are putting on weight on Mounjaro, a question worth reading if the scales are not moving as expected alongside GI changes. Speak to our prescribers through a free consultation, your pen arrives the next working day via DPD in plain, unbranded packaging, and clinical support is there before it does.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.